Key Takeaway
The ketogenic diet achieves seizure freedom in approximately 25-55% of patients with drug-resistant epilepsy, with over 50% of patients experiencing at least a 50% reduction in seizure frequency.
Summary
This paper provides a comprehensive overview of existing systematic reviews and meta-analyses evaluating the ketogenic diet (KD) as a treatment for epilepsy. The authors synthesized evidence from multiple high-level reviews to assess the overall efficacy, safety, and tolerability of ketogenic dietary therapies, including the classic KD, modified Atkins diet (MAD), and medium-chain triglyceride (MCT) diet.
The aggregated evidence demonstrates that ketogenic dietary therapies are effective for reducing seizure frequency in patients with drug-resistant epilepsy across both pediatric and adult populations. The analysis found that a substantial proportion of patients achieve clinically meaningful seizure reduction, with some attaining complete seizure freedom. The authors also reviewed the side effect profile, noting that while gastrointestinal symptoms, dyslipidemia, and kidney stones can occur, these are generally manageable with appropriate monitoring.
The overview concludes that ketogenic dietary therapies represent a valuable treatment option for drug-resistant epilepsy, supported by a robust body of systematic review evidence. The authors recommend further high-quality randomized controlled trials to strengthen the evidence base and better define optimal dietary protocols.
Methods
Systematic search and narrative synthesis of existing systematic reviews and meta-analyses evaluating ketogenic dietary therapies for epilepsy. The authors identified and analyzed multiple published reviews covering various ketogenic diet protocols across pediatric and adult populations with drug-resistant epilepsy.
Key Results
Across the reviewed meta-analyses, approximately 25-55% of patients on ketogenic diets achieved seizure freedom, and more than 50% of patients experienced at least a 50% reduction in seizure frequency. The classic ketogenic diet and modified Atkins diet showed comparable efficacy. Side effects were generally mild to moderate and included gastrointestinal symptoms, elevated cholesterol, and kidney stones, though serious adverse events were rare.
Limitations
As an overview of reviews, this study relies on previously published meta-analyses and inherits their limitations. Most underlying studies were observational or had small sample sizes. There was heterogeneity in diet protocols, seizure types, and outcome measures across the included reviews. High-quality RCTs remain limited in this field.